Faculty Opinions recommendation of Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma.
Year: 2016
Type: peer-review
Author: Ashani Weeraratna
Institution: The Wistar Institute
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4248904172